| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 3 | |
| #2 | Canada | 3 | |
| #3 | EPO (European Patent Office) | 3 | |
| #4 | Mexico | 3 | |
| #5 | WIPO (World Intellectual Property Organization) | 3 | |
| #6 | Brazil | 2 | |
| #7 | China | 2 | |
| #8 | Israel | 2 | |
| #9 | Republic of Korea | 2 | |
| #10 | Argentina | 1 | |
| #11 | Costa Rica | 1 | |
| #12 | EAPO (Eurasian Patent Organization) | 1 | |
| #13 | India | 1 | |
| #14 | Philippines | 1 | |
| #15 | Singapore | 1 | |
| #16 | Taiwan | 1 | |
| #17 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Environmental technology | |
| #3 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Climate change adaptation technologies | |
| #4 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Lewin Matthew R | 26 |
| #2 | Matthew R Lewin | 4 |
| #3 | Carter Rebecca | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021076712A1 | Early management and prevention of sepsis and sepsis-like syndromes | |
| CN109562098A | Treatment causes PLA2 the and HMG-COA inhibitor of the pathological state of haemolysis, the cerebrovascular and acute kidney injury | |
| KR20170086089A | Envenomation therapies and related pharmaceutical compositions, systems and kits | |
| AU2013312240A1 | Administration of acetylcholinesterase inhibitors to mitigate neurotoxin-induced paralysis and residual neuromuscular blockade |